Literature DB >> 26460603

Contractile properties of developing human fetal cardiac muscle.

Alice W Racca1, Jordan M Klaiman1, J Manuel Pioner2, Yuanhua Cheng1, Anita E Beck3,4, Farid Moussavi-Harami5, Michael J Bamshad3,4, Michael Regnier1,6,7.   

Abstract

KEY POINTS: The contractile properties of human fetal cardiac muscle have not been previously studied. Small-scale approaches such as isolated myofibril and isolated contractile protein biomechanical assays allow study of activation and relaxation kinetics of human fetal cardiac muscle under well-controlled conditions. We have examined the contractile properties of human fetal cardiac myofibrils and myosin across gestational age 59-134 days. Human fetal cardiac myofibrils have low force and slow kinetics of activation and relaxation that increase during the time period studied, and kinetic changes may result from structural maturation and changes in protein isoform expression. Understanding the time course of human fetal cardiac muscle structure and contractile maturation can provide a framework to study development of contractile dysfunction with disease and evaluate the maturation state of cultured stem cell-derived cardiomyocytes. ABSTRACT: Little is known about the contractile properties of human fetal cardiac muscle during development. Understanding these contractile properties, and how they change throughout development, can provide valuable insight into human heart development, and provide a framework to study the early stages of cardiac diseases that develop in utero. We characterized the contractile properties of isolated human fetal cardiac myofibrils across 8-19 weeks of gestation. Mechanical measurements revealed that in early stages of gestation there is low specific force and slow rates of force development and relaxation, with increases in force and the rates of activation and relaxation as gestation progresses. The duration and slope of the initial, slow phase of relaxation, related to myosin detachment and thin filament deactivation rates, decreased with gestation age. F-actin sliding on human fetal cardiac myosin-coated surfaces slowed significantly from 108 to 130 days of gestation. Electron micrographs showed human fetal muscle myofibrils elongate and widen with age, but features such as the M-line and Z-band are apparent even as early as day 52. Protein isoform analysis revealed that β-myosin is predominantly expressed even at the earliest time point studied, but there is a progressive increase in expression of cardiac troponin I (TnI), with a concurrent decrease in slow skeletal TnI. Together, our results suggest that cardiac myofibril force production and kinetics of activation and relaxation change significantly with gestation age and are influenced by the structural maturation of the sarcomere and changes in contractile filament protein isoforms.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26460603      PMCID: PMC4713728          DOI: 10.1113/JP271290

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  52 in total

1.  Analysis of myosin heavy chain functionality in the heart.

Authors:  Maike Krenz; Atsushi Sanbe; Florence Bouyer-Dalloz; James Gulick; Raisa Klevitsky; Timothy E Hewett; Hanna E Osinska; John N Lorenz; Christine Brosseau; Andrea Federico; Norman R Alpert; David M Warshaw; M Benjamin Perryman; Steve M Helmke; Jeffrey Robbins
Journal:  J Biol Chem       Date:  2003-03-06       Impact factor: 5.157

2.  A simple model with myofilament compliance predicts activation-dependent crossbridge kinetics in skinned skeletal fibers.

Authors:  D A Martyn; P B Chase; M Regnier; A M Gordon
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

3.  Relaxation kinetics following sudden Ca(2+) reduction in single myofibrils from skeletal muscle.

Authors:  Chiara Tesi; Nicoletta Piroddi; Francesco Colomo; Corrado Poggesi
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

4.  Scanning electron microscopy of fetal and neonatal lamb cardiac cells.

Authors:  C A Sheldon; W F Friedman; H D Sybers
Journal:  J Mol Cell Cardiol       Date:  1976-11       Impact factor: 5.000

5.  Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles.

Authors:  P J Reiser; M A Portman; X H Ning; C Schomisch Moravec
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

6.  Systolic and diastolic function of the fetal single left ventricle.

Authors:  Paul A Brooks; Nee S Khoo; Lisa K Hornberger
Journal:  J Am Soc Echocardiogr       Date:  2014-09       Impact factor: 5.251

7.  Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing hearts.

Authors:  I F Purcell; W Bing; S B Marston
Journal:  Cardiovasc Res       Date:  1999-09       Impact factor: 10.787

8.  Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart.

Authors:  Sharon Siedner; Martina Krüger; Mechthild Schroeter; Doris Metzler; Wilhelm Roell; Bernd K Fleischmann; Juergen Hescheler; Gabriele Pfitzer; Robert Stehle
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

9.  PKA phosphorylation of cardiac troponin I modulates activation and relaxation kinetics of ventricular myofibrils.

Authors:  Vijay Rao; Yuanhua Cheng; Steffen Lindert; Dan Wang; Lucas Oxenford; Andrew D McCulloch; J Andrew McCammon; Michael Regnier
Journal:  Biophys J       Date:  2014-09-02       Impact factor: 4.033

10.  Reference values for fetal tissue velocity imaging and a new approach to evaluate fetal myocardial function.

Authors:  Nina Ne Elmstedt; Jonas Jj Johnson; Britta Bl Lind; Kjerstin Kfw Ferm-Widlund; Lotta Lh Herling; Magnus Mw Westgren; Lars-Åke Lab Brodin
Journal:  Cardiovasc Ultrasound       Date:  2013-08-16       Impact factor: 2.062

View more
  23 in total

1.  Why we need to understand the mechanics of developing cardiac sarcomeres in humans.

Authors:  R John Solaro
Journal:  J Physiol       Date:  2016-01-15       Impact factor: 5.182

2.  Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy.

Authors:  Alexey V Dvornikov; Mingmin Wang; Jingchun Yang; Ping Zhu; Tai Le; Xueying Lin; Hung Cao; Xiaolei Xu
Journal:  J Mol Cell Cardiol       Date:  2019-06-20       Impact factor: 5.000

Review 3.  Fetal programming as a predictor of adult health or disease: the need to reevaluate fetal heart function.

Authors:  Joana O Miranda; Carla Ramalho; Tiago Henriques-Coelho; José Carlos Areias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

4.  A transcriptomics resource reveals a transcriptional transition during ordered sarcomere morphogenesis in flight muscle.

Authors:  Maria L Spletter; Christiane Barz; Assa Yeroslaviz; Xu Zhang; Sandra B Lemke; Adrien Bonnard; Erich Brunner; Giovanni Cardone; Konrad Basler; Bianca H Habermann; Frank Schnorrer
Journal:  Elife       Date:  2018-05-30       Impact factor: 8.140

5.  Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest.

Authors:  Richard J Mills; Drew M Titmarsh; Xaver Koenig; Benjamin L Parker; James G Ryall; Gregory A Quaife-Ryan; Holly K Voges; Mark P Hodson; Charles Ferguson; Lauren Drowley; Alleyn T Plowright; Elise J Needham; Qing-Dong Wang; Paul Gregorevic; Mei Xin; Walter G Thomas; Robert G Parton; Lars K Nielsen; Bradley S Launikonis; David E James; David A Elliott; Enzo R Porrello; James E Hudson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-15       Impact factor: 11.205

6.  Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.

Authors:  J Manuel Pioner; Xuan Guan; Jordan M Klaiman; Alice W Racca; Lil Pabon; Veronica Muskheli; Jesse Macadangdang; Cecilia Ferrantini; Michael R Hoopmann; Robert L Moritz; Deok-Ho Kim; Chiara Tesi; Corrado Poggesi; Charles E Murry; Martin K Childers; David L Mack; Michael Regnier
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

7.  Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Cinsley Gentillon; Dong Li; Meixue Duan; Wen-Mei Yu; Marcela K Preininger; Rajneesh Jha; Antonio Rampoldi; Anita Saraf; Gregory C Gibson; Cheng-Kui Qu; Lou Ann Brown; Chunhui Xu
Journal:  J Mol Cell Cardiol       Date:  2019-05-11       Impact factor: 5.000

8.  A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.

Authors:  K M Broughton; J Li; E Sarmah; C M Warren; Y-H Lin; M P Henze; V Sanchez-Freire; R J Solaro; B Russell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

9.  Growing up gator: a proteomic perspective on cardiac maturation in an oviparous reptile, the American alligator (Alligator mississippiensis).

Authors:  Sarah L Alderman; Dane A Crossley; Ruth M Elsey; Todd E Gillis
Journal:  J Comp Physiol B       Date:  2020-01-22       Impact factor: 2.200

10.  Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy.

Authors:  Hadi R Ali; Cole R Michel; Ying H Lin; Timothy A McKinsey; Mark Y Jeong; Amrut V Ambardekar; Joseph C Cleveland; Richard Reisdorph; Nichole Reisdorph; Kathleen C Woulfe; Kristofer S Fritz
Journal:  J Mol Cell Cardiol       Date:  2019-12-10       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.